Innovating Works

E.M.S.P.

Desconocido
EBV-MS: Targeting Epstein Barr Virus Infection for Treatment and Prevention of Multiple Sclerosis THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS). It constitutes the most comm...
2023-11-10 - 2028-11-30 | Financiado
More-EUROPA: More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL participó en un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11 While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real world...
2022-11-24 - 2027-12-31 | Financiado
DO-IT: Big Data for Better Outcomes Policy Innovation and Healthcare System Transformation Sofia ref. 1... THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL participó en un H2020: H2020-JTI-IMI2-2015-07-two-stage The overall goal of the Big Data for Better Outcomes (BD4BO) programme is to facilitate the use of ‘big data’ to promote the development of...
2017-01-30 - 2019-01-31 | Financiado
N2B-patch: Nose to Brain Delivery of Antibodies via the Olfactory Region for the Treatment of Multiple Sclerosi... THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL participó en un H2020: H2020-NMBP-2016-2017 The overall aim of N2B-patch is the development of a new innovative N2B drug delivery technology based on the synthesis of a biomaterial-bas...
2016-11-09 - 2021-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.